# KBI Biopharma Inc. — Form D

KBI Biopharma Inc. of DURHAM, NC, a company, filed a Form D exempt-offering notice with the SEC on 2009-09-23. The offering totals $10.0M, of which $9.6M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2009-09-23
- Form: D
- Accession: 0001314013-09-000004
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $10.0M
- Amount sold: $9.6M
- Remaining: $400K
- Minimum investment: $10K
- Investors: 9
- Date of first sale: 2009-08-14
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-72839

## Issuer

- Name: KBI Biopharma Inc.
- CIK: 0001314013
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 1101 HAMLIN RD, DURHAM, NC, 27704
- Phone: 919-479-9898

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| Howard Auman, Jr. | Director | Durham, NC |
| Harrington Bischof | Director | Durham, NC |
| Richard Brandewie | Director | St. Petersburg, FL |
| James Hoover | Director | Great Falls, VA |
| Joseph McMahon | Director | Durham, NC |
| Nicholas J Leb | Executive Officer | Durham, NC |
| Joseph McMahon | Executive Officer | Durham, NC |

## More

- [CIK 1314013 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1314013&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001314013-09-000004.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.